Difference between revisions of "P40"

Jump to navigation Jump to search
398 bytes added ,  17:34, 20 December 2016
Line 30: Line 30:
*Breast carcinoma.
*Breast carcinoma.
**CK5 +ve breast carcinomas are typically p40 positive.<ref name=pmid26330357>{{Cite journal  | last1 = Kővári | first1 = B. | last2 = Szász | first2 = AM. | last3 = Kulka | first3 = J. | last4 = Marušić | first4 = Z. | last5 = Šarčević | first5 = B. | last6 = Tiszlavicz | first6 = L. | last7 = Cserni | first7 = G. | title = Evaluation of p40 as a Myoepithelial Marker in Different Breast Lesions. | journal = Pathobiology | volume = 82 | issue = 3-4 | pages = 166-71 | month = Sep | year = 2015 | doi = 10.1159/000375127 | PMID = 26330357 }}</ref>
**CK5 +ve breast carcinomas are typically p40 positive.<ref name=pmid26330357>{{Cite journal  | last1 = Kővári | first1 = B. | last2 = Szász | first2 = AM. | last3 = Kulka | first3 = J. | last4 = Marušić | first4 = Z. | last5 = Šarčević | first5 = B. | last6 = Tiszlavicz | first6 = L. | last7 = Cserni | first7 = G. | title = Evaluation of p40 as a Myoepithelial Marker in Different Breast Lesions. | journal = Pathobiology | volume = 82 | issue = 3-4 | pages = 166-71 | month = Sep | year = 2015 | doi = 10.1159/000375127 | PMID = 26330357 }}</ref>
*[[Prostate carcinoma]].<ref name=pmid25852959>{{Cite journal  | last1 = Brustmann | first1 = H. | title = p40 as a Basal Cell Marker in the Diagnosis of Prostate Glandular Proliferations: A Comparative Immunohistochemical Study with 34betaE12. | journal = Patholog Res Int | volume = 2015 | issue =  | pages = 897927 | month =  | year = 2015 | doi = 10.1155/2015/897927 | PMID = 25852959 }}</ref>


==See also==
==See also==
48,475

edits

Navigation menu